Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R22 - Effective April 1, 2025 Apr 04, 2025
Billing and Coding: MolDX: Proteomics Testing (A59641) - R8 - Effective April 1, 2025 Apr 04, 2025
Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57901) - R7 - Effective April 1, 2025 Apr 04, 2025
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R16 - Effective April 1, 2025 Apr 04, 2025
Billing and Coding: Leadless Pacemakers (A59819) - R3 - Effective October 08, 2024 Apr 03, 2025
April 2025 CPT/HCPCS Billing and Coding Article Updates Mar 28, 2025
Billing and Coding: Epidural Steroid Injections for Pain Management (A58993) - R4 - Effective June 19, 2022 Mar 20, 2025
Billing and Coding: Guardant360® (A58192) Retirement - Effective December 25, 2022 Mar 17, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720)- R24- Effective March 13, 2025 Mar 14, 2025
MolDX: Prometheus IBD sgi Diagnostic Policy (L37299) - R8 - Effective March 13, 2025 Mar 14, 2025
MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules (L39682) - R1 - Effective March 13, 2025 Mar 14, 2025
MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia (L39262) - R1 - Effective March 13, 2025 Mar 14, 2025
MolDX: Plasma-Based Genomic Profiling in Solid Tumors (L39230) - R1 - Effective March 6, 2025 Mar 07, 2025
Intervertebral Disc Repair Final LCD - Effective April 13, 2025 Feb 27, 2025
Policy Revision(s) for Local Coverage Determinations - Effective February 14, 2025 Feb 20, 2025
Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) - Published for Review and Comments Feb 10, 2025
Open Public Meeting Announcement - Allergy Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) - March 6, 2025 Feb 10, 2025
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R9 - Effective November 18, 2024 Feb 10, 2025
MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (L39001) - R3 - Effective January 30, 2025 Feb 06, 2025
Billing and Coding: Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea (A57948) - R4 - Effective December 1, 2024 Jan 30, 2025